top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cell-Free Nucleic Acids
Cell-Free Nucleic Acids
Autore Nagy Bálint
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (248 p.)
Soggetto topico Medicine
Soggetto non controllato aging
biomarker
blood plasma
breast cancer
C19MC microRNA
CDH1
cell-free DNA
cell-free DNAs
cell-free nucleic acids
cell-free RNAs
cfDNA
circulating miRNA
circulating nucleic acids
circulating tumor cells
copy number variants
deletion/insertion polymorphism
DNA
embryo culture medium
exosomes
expression
extracellular vesicles
fetal cells
fetal DNA
fetal fraction
fetal growth restriction
gender differences
genetic marker
gestational diabetes mellitus
gestational hypertension
growth retardation
hematopoietic stem cell transplantation
individualized patient profile
inflammatory bowel disease
leiomyomas
leiomyosarcomas
liquid biopsy
mammography
maternal serum screening
microchimerism
miRNA
multi-level diagnostics
n/a
NanoString
NETosis
network analysis
neutrophil extracellular traps
next generation sequencing
NGS
NIPT
non-invasive prenatal testing
nuclease activity
obesity
omics
ovarian cancer
PAX1
personalized medicine
piRNA
plasma
population study
prediction
predictive and preventive approach
preeclampsia
pregnancy-related complications
PTEN
pyrosequencing
RASSF1
RT-PCR
sarcomas
screening
single nucleotide polymorphism
solid organ transplantation
statistical methods
statistical models
z-score
ISBN 3-03928-075-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910372783603321
Nagy Bálint  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Multimodality Treatments in Metastatic Gastric Cancer
Multimodality Treatments in Metastatic Gastric Cancer
Autore Petrillo Angelica
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (162 p.)
Soggetto topico Medicine
Soggetto non controllato advanced gastric cancer
biomarkers
body composition
bone flare
CAR T cell therapy
cfDNA
circulating tumor cell
conversion surgery
ctDNA
epithelial-mesenchymal transition
Epstein Barr Virus
exome sequencing
formalin fixed paraffin embedded
gastric cancer
gastro-oesophageal cancer
hepatectomy
HER2-inhibition
immune checkpoint inhibitors
immunotherapy
liquid biopsy
liver metastasis
metastatic
metastatic gastric cancer
microsatellite instability
mutational concordance
n/a
new drug development
nutritional status
outcome
precision medicine
predictive biomarkers
RANK-L
resistance to treatment
response monitoring
sarcopenia
stage IV
stage iv gastric cancer
subcutaneous fat area
target therapy
toxicity
treatment
tumor mutational burden
vaccines
VEGFR-inhibition
visceral fat area
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557390503321
Petrillo Angelica  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Precision Medicine in Solid Tumors
Precision Medicine in Solid Tumors
Autore Dey Nandini
Descrizione fisica 1 online resource (304 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato adjuvant chemotherapy
anaplastic lymphoma receptor tyrosine kinase
breast cancer
cancer
cancer-associated fibroblasts
cfDNA
chemotherapy
circulating free DNA
clinical guideline
clonality classification
comprehensive genomic profiling
CTC
ctDNA
DDR genes
Decision tree
digital enrichment
driver mutation
EGFR mutation
EGFR-TKI
electronic records
epidermal growth factor receptor
extent of resection
gene panel sequencing
glioblastoma prognosis
HNSCC
immune checkpoint inhibitors
immunocytochemistry
immunotherapy
intratumor heterogeneity
laboratory-friendly
liquid biopsy
molecular barcoding
molecular genotyping
multiple biopsies
n/a
new drug development
next-generation sequencing
next-generation sequencing (NGS)
NGS
non-small cell lung cancer
open data
osimertinib
outcome
overall survival
parallel double-detection
PARP inhibitors
PD-L1
pediatric tumors
personalized precision oncology
precision medicine
presumed germline findings
random forest
regulatory reform
resistance
screening
sequencing
smoking
solid cancer
strategic therapeutic intervention
targeted therapy
tDNA
thymoma
TMB
TNBC subtypes
triple-negative breast cancer (TNBC)
tumor evolution
tumor mutational burden
tumor profiling test
tyrosine kinase inhibitor
universal health-care system
whole-exome sequencing
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595078103321
Dey Nandini  
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui